Mammalian Transient Protein Expression Market to Register 9.0% CAGR, Surpassing US$ 12,712 Mn by 2030 - Future Market Insights, Inc.

May 10, 2022

Major companies operating in the global market include: Thermofisher Scientific, Merck KGaA, Promega Corporation, Lonza, Agilent Technologies, Inc., Bio-Rad, Qiagen, Takara Bio, HiMedia Laboratories., Mirus, Sino Biological, Inc.

NEWARK, Del., May 9, 2022 /PRNewswire/ -- Global mammalian transient protein market revenues are projected to surpass US$ 641.0 Mn in 2022, likely to surge at a vigorous 9.0% CAGR during the assessment period according to a new study by Future Market Insights (FMI). The report also states that innovations in automation and recombinant proteins will support market developments, however, prohibitive costs and the complexity to maintain media purity remain challenges.

Key Takeaways on Mammalian Transient Protein Expression Market

  • The size of the mammalian transient protein expression market is estimated to reach approximately US$ 540 Mn by the end of 2020, with antibody and therapeutic protein production applications being the primary factors driving growth in the industry.
  • Biopharmaceutical companies will remain prominent end-users of mammalian transient protein expression, while CROs are also likely to reflect steady growth on the back of biologics and drug development endeavours.
  • Chinese hamster ovary cells in terms of cell lines reflect relatively higher demand, owing to applications in academic and research uses, accounting for ~70% of market share by 2030.
  • North America followed by Europe are leading markets for mammalian transient protein expression, access to cutting edge healthcare technologies, and the presence of leading market players.

Request a sample @

Covid-19 Impact on Mammalian Transient Protein Expression Market

The Impact of the covid-19 pandemic on the mammalian transient protein expression market has largely been negative. Strict lockdown and social distancing regulations have resulted in delayed projects in research and biomedicine applications.

Also, market players have witnessed lower sales and revenue during the crisis period arising from supply chain disruptions, and a shortage of adequate manpower. On the other hand, the potential for applications in vaccine development is likely to provide opportunities for short-term growth, moderately mitigating loss during this period.

Leading Companies Profiled in Mammalian Transient Protein Expression Market are

  • Thermofisher Scientific
  • Merck KGaA
  • Promega Corporation
  • Lonza
  • Agilent Technologies, Inc.
  • Bio-Rad
  • Qiagen
  • Takara Bio
  • HiMedia Laboratories.
  • Mirus
  • Sino Biological, Inc.

Who is Winning?

In its latest report, Future Market Insights has provided details on key business strategies that are gaining importance in the mammalian transient protein expression market. Market leaders in the industry have been pushing for the expansion of their portfolios with offerings associated with antibody development and gene coding. Also, strategic collaborations are gaining ground in the sector.

Merck KgaA, Thermo Fisher Scientific, Agilent Technologies Inc., Lonza, Mirus Bio Inc., Takara Bio Inc., Qiagen N.V., and Bio-Rad Laboratories Inc., are some of the key companies operating in the mammalian transient protein expression market.

Request for PDF Brochure @

Key Market Segments Covered in Mammalian Transient Protein Expression Industry Research

By Product:

  • Instruments
  • Expression Vector
  • Reagents Consumables
  • Cell Lines
    • Chinese Hamster Ovary Cells (CHO)
    • Human embryonic kidney 293 (HEK 293) cells
    • Others

By Application:

  • Bio-productio
    • Antibody Production
    • Therapeutic protein production
  • Functional Cell-Based Assays
  • Academic Research
  • Others

By End-User:

  • Contract Research Organization
  • Biopharmaceutical Companies
  • Academic Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA).

Get Customization on this Report for Specific [email protected]

Why Future Market Insights?

  • Comprehensive analysis of evolving purchase patterns across different geographies
  • Detailed insights of market segments and sub-segments for historical as well as the forecast period
  • A competitive analysis of prominent players and emerging players in the keyword market
  • Detailed information about the product innovation, mergers and acquisitions lined up in upcoming Groundbreaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Explore wide-ranging Coverage of FMI's Healthcare Market Insights Landscape

Anti-Asthma TDM Assay Kits Market – The anti-asthma TDM assay kits market is anticipated to grow at a CAGR of 4.5% during the forecast period with a valuation of US$ 18 Bn in 2022.

Intranasal Corticosteroids Market – The anti-asthma TDM assay kits market is anticipated to grow at a CAGR of 4.5% during the forecast period with a valuation of US$ 18 Bn in 2022.

Antinuclear Antibody Test Market – The antinuclear antibody test market is likely to record a strong CAGR of 8% during the forecast period. The antinuclear antibody test market is currently valued at US$ 7.4 Bn in 2022 and is likely to reach US$ 17.25 Bn by 2032.

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End-Use over the next 10-years.

Contact: Future Market Insights Inc. Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, USA T: +1-845-579-5705 For Sales Enquiries:  [email protected]   Website:  Report:  LinkedIn | Twitter| Blogs

SOURCE Future Market Insights

Related Posts